Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06633419
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-07
Brief Title:
A Drug-Drug Interaction Study of Carbamazepine and Opevesostat MK-5684 in Healthy Adult Male Participants MK-5684-012
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Open-Label Fixed-Sequence Study to Evaluate the Effects of Multiple Doses of Carbamazepine on the Single-Dose Pharmacokinetics of MK-5684 in Healthy Adult Male Participants
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Researchers have designed a study medicine called opevesostat as a new way to treat prostate cancer
The purpose of this study is to learn what happens to opevesostat in a persons body over time a pharmacokinetic or PK study Researchers will compare what happens to opevesostat in the body when it is given with and without another medicine called carbamazepine
The purpose of this study is to learn what happens to opevesostat in a persons body over time a pharmacokinetic or PK study Researchers will compare what happens to opevesostat in the body when it is given with and without another medicine called carbamazepine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None